share_log

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

Benzinga ·  May 18, 2023 08:16

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment